At J.P. Morgan, A Sense That The Long-Promised Biotech Future Has Arrived; Is Tech Disruption Next?


There’s been remarkable progress in the tools available for collecting and analyzing data. These tools are too powerful and too important not to impact how we think about biology and drug discovery. The question is how to bring these tools to bear in developing impactful new medicines for patients.January 13, 2018 at 01:38AM

via Forbes Real Time http://ift.tt/2mCAbsb